Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence ...

A multicentre study found that an AI model using routine H&E pathology slides and clinicopathological data could estimate genomic recurrence risk and predict chemotherapy benefit in hormone ...

Craig Griffeth, 74, has always worried about cancer. “My aunts and uncles, almost all of them on both sides, died of cancer,” he said. “So, I figured that one day I’m going to get cancer, and I’ll ...

The funding will help transition the company’s AI lymphoma diagnostic into clinical use, with initial deployments in NHS ...